Vijaya Diagnostic Centre Ltd (VIJAYA) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Vijaya Diagnostic Centre reported strong financial results for Q4 FY25 and the full fiscal year, driven by test volume growth.
- Revenue for Q4 FY25 reached INR 173 crores, a 12% YoY increase, with 13% organic growth.
- Full-year revenue reached INR 681 crores, a 24% YoY increase, with 19% organic growth.
- EBITDA margin for Q4 FY25 stood at a healthy 39.8%, while the full-year EBITDA margin was 40.1%.
- The company successfully launched six new hubs in Pune, Bengaluru, and West Bengal, expanding its presence in key markets.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.